Get the Stockscreener App
4.39
7.07%
0.29
Pre-market:
4.44
0.05
+1.14%
Intelligent Bio Solutions Inc stock is traded at $4.39, with a volume of 43,842.
It is up +7.07% in the last 24 hours and down -36.88% over the past month.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.
See More
Previous Close:
$4.10
Open:
$4.18
24h Volume:
43,842
Relative Volume:
0.02
Market Cap:
$7.04M
Revenue:
$3.19M
Net Income/Loss:
$-10.42M
P/E Ratio:
-0.1237
EPS:
-35.4757
Net Cash Flow:
$-10.65M
1W Performance:
+10.86%
1M Performance:
-36.88%
6M Performance:
-71.12%
1Y Performance:
-78.48%
1-Day Range:
$4.03
$4.50
1-Week Range:
$3.80
$4.8999
52-Week Range:
$3.70
$25.00
Intelligent Bio Solutions Inc Stock (INBS) Company Profile
Name
Intelligent Bio Solutions Inc
Sector
Industry
Phone
646-790-5756
Address
135 W 41ST ST,, NEW YORK
Compare INBS vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INBS
Intelligent Bio Solutions Inc
|
4.39 | 6.58M | 3.19M | -10.42M | -10.65M | -35.48 |
|
ABT
Abbott Laboratories
|
113.10 | 197.42B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
381.89 | 147.18B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
95.60 | 124.16B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
72.21 | 109.58B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.22 | 49.49B | 6.07B | 1.06B | 1.34B | 1.8063 |
Intelligent Bio Solutions Inc Stock (INBS) Latest News
Intelligent Bio Solutions Scales Manufacturing to Fuel Growth and U.S. Ambitions - AD HOC NEWS
Jobs Data: How cyclical is Intelligent Bio Solutions Incs revenue stream2025 Price Momentum & Daily Profit Focused Stock Screening - baoquankhu1.vn
INBS receives first reader shipment from Syrma Johari partnership By Investing.com - Investing.com Australia
INBS receives first reader shipment from Syrma Johari partnership - Investing.com
Intelligent Bio Solutions Expands Manufacturing Capacity and Deployment - TipRanks
Intelligent Bio Solutions Inc. Plans U.S. Market Entry in 2026 - marketscreener.com
Why Did INBS Stock Jump 11% In Pre-Market Today? - Asianet Newsable
Intelligent Bio Solutions ships first readers with Syrma Johari, targets 40% production cost cuts - TradingView
INBS Stock Reverses Early Gains After First Shipment of Drug Screening Readers Under Syrma Johari MedTech Partnership - Stocktwits
Intelligent Bio Solutions announces delivery in partnership with Syrma Johari - marketscreener.com
Intelligent Bio Solutions (INBS) targets 40%+ cost savings with new Syrma Johari manufacturing - Stock Titan
Intelligent Bio Solutions Successfully Manufactures and Ships First Readers with New Partner, Accelerating Scale and Driving Gross Margin Expansion in Anticipation of Planned U.S. Entry - The Manila Times
Intelligent Bio Solutions Announces Delivery In Partnership With Syrma Johari - TradingView
Drug test readers scaled 4x as Intelligent Bio preps for U.S. entry - Stock Titan
Aug Final Week: What are the analyst revisions for CLFDIs ARQQW stock a good investment in YEARTrend Reversal & Fast Moving Trade Plans - baoquankhu1.vn
Aug Fed Impact: Will D Wave Quantum Inc Equity Warrant stock benefit from M AJuly 2025 Breakouts & Verified Swing Trading Watchlists - baoquankhu1.vn
Intelligent Bio Solutions (INBS) Collaborates with Bouygues UK o - GuruFocus
Intelligent Bio Solutions Partners with Bouygues UK, Part of Multi-Billion Dollar Global Construction Giant Bouygues Construction, for UK Drug Testing Rollout - marketscreener.com
Intelligent Bio Solutions partners with Bouygues UK - marketscreener.com
Intelligent Bio Solutions Partners With Bouygues UK - TradingView
Intelligent Bio Solutions Inc. Partners with Bouygues UK for Deployment of Fingerprint Drug Screening Technology - Quiver Quantitative
Construction giant brings drug tests in-house with fingerprint scans at UK sites - Stock Titan
EPS Watch: Should I buy Intelligent Bio Solutions Inc stock now2025 Macro Impact & AI Based Buy/Sell Signal Reports - baoquankhu1.vn
INBS Should I Buy - Intellectia AI
Is Intelligent Bio Solutions Inc. a defensive stock2025 Analyst Calls & Smart Investment Allocation Tips - mfd.ru
Can Intelligent Bio Solutions Inc. maintain its current growth rateWeekly Risk Report & Consistent Profit Trade Alerts - mfd.ru
Is Intelligent Bio Solutions Inc. being accumulated by smart moneyWeekly Trend Report & Free Technical Pattern Based Buy Signals - mfd.ru
Intelligent Bio Solutions reports record fiscal second quarter revenue growth of 48% with reader sales surging 104% year-over-year - marketscreener.com
INBS Sees Strong Revenue Growth in Q2 - GuruFocus
Intelligent Bio Solutions Reports Record Fiscal Second Quarter Revenue Growth Of 48% With Reader Sales Surging 104% Year-Over-Year - TradingView
Intelligent Bio Solutions Reports Record Fiscal Second Quarter Revenue Growth of 48% with Reader Sales Surging 104% Year-Over-Year - The Manila Times
INTELLIGENT BIO SOLUTIONS INC's recently released fiscal second quarter earnings report shows the company achieved record revenue growth, with quarterly revenue surging 48% year-over-year. - Bitget
INTELLIGENT BIO SOLUTIONS INC. SEC 10-Q Report - TradingView
Can Intelligent Bio Solutions Inc. stock deliver consistent earnings growthLong Setup & Weekly Momentum Stock Picks - mfd.ru
Is Intelligent Bio Solutions Inc.’s growth already priced inEarnings Recap Report & Technical Buy Zone Confirmations - mfd.ru
Intelligent Bio Solutions Expects to Report Fiscal Second Quarter 2026 Revenue Growth of Approximately 48% Year-Over-Year, Surpassing $2 Million in Total Revenue for First Half of Fiscal Year - The Manila Times
Intelligent Bio Solutions Inc. Anticipates Record Revenue Growth in Fiscal Q2 2026 Driven by Strong Customer Base Expansion - Quiver Quantitative
How cyclical is Intelligent Bio Solutions Inc.’s revenue streamJuly 2025 PreEarnings & AI Driven Stock Reports - mfd.ru
Intelligent Bio Solutions begins clinical studies for FDA clearance By Investing.com - Investing.com Nigeria
Intelligent Bio Solutions Launches Codeine Screening Clinical Program - TipRanks
Intelligent Bio Solutions Inc Initiates Clinical Studies for FDA Submission - TradingView
Intelligent Bio Solutions begins clinical studies for FDA clearance - Investing.com
INBS Embarks on Clinical Study for Drug Screening System FDA App - GuruFocus
Intelligent Bio Solutions initiates additional studies for FDA 510k submission - TipRanks
Intelligent Bio Solutions Initiates Additional Clinical - GlobeNewswire
Intelligent Bio Solutions Initiates Additional Clinical Studies for FDA 510(k) Submission Supporting Planned Entry into Multi-Billion Dollar U.S. Market - The Manila Times
Fundamentals Check: Is Intelligent Bio Solutions Inc stock risky to hold now2025 Performance Recap & Long-Term Investment Growth Plans - baoquankhu1.vn
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Intelligent Bio Solutions Forges Manufacturing Alliance With Syrma Johari Medtech - Medical Product Outsourcing
Is Riverview Bancorp Inc. stock positioned well for digital economy2025 Major Catalysts & Advanced Swing Trade Entry Plans - bollywoodhelpline.com
Is Intelligent Bio Solutions Inc. stock a buy on dipsWeekly Investment Recap & Safe Capital Growth Stock Tips - bollywoodhelpline.com
Intelligent Bio Solutions Inc Stock (INBS) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.27%
1.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):